Shree Ganesh Remedies Intrinsic Value
Shree Ganesh Remedies (SGRL) median intrinsic value is ₹301.58 from 9 valuation models (range ₹194–₹429), vs current price ₹648.25 — -53.5% downside (Trading Above Calculated Value), margin of safety -100.0%. For current market price and key ratios, visit SGRL share price screener.
SGRL Valuation Methods Summary — DCF, Graham Number & P/E
Shree Ganesh Remedies intrinsic value across 9 models vs current price ₹648.25 — upside/downside and value range per method. Also explore SGRL share price data to track price trends across different timeframes.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹429.44 | ₹343.55 - ₹515.33 | -33.8% | EPS: ₹19.52, Sector P/E: 22x |
| Book Value Method | asset | ₹250.77 | ₹225.69 - ₹275.85 | -61.3% | Book Value/Share: ₹125.38, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹209.23 | ₹188.31 - ₹230.15 | -67.7% | Revenue/Share: ₹104.62, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹369.23 | ₹332.31 - ₹406.15 | -43.0% | EBITDA: ₹48.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹323.91 | ₹259.13 - ₹388.69 | -50.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹194.47 | ₹175.02 - ₹213.92 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹301.58 | ₹271.42 - ₹331.74 | -53.5% | Revenue Growth: 6.0%, Adj P/E: 15.5x |
| ROE Based Valuation | profitability | ₹324.12 | ₹291.71 - ₹356.53 | -50.0% | ROE: 14.7%, P/E Multiple: 12x |
| Graham Defensive Method | conservative | ₹234.67 | ₹211.20 - ₹258.14 | -63.8% | EPS: ₹19.52, BVPS: ₹125.38 |
SGRL Intrinsic Value vs Market Price — All Valuation Models
Shree Ganesh Remedies fair value range ₹194–₹429 vs current market price ₹648.25 across 9 valuation models. Browse SGRL financial statements for revenue, profit, balance sheet and cash flow data.
SGRL Intrinsic Value Analysis — Undervalued or Overvalued?
Shree Ganesh Remedies median intrinsic value ₹301.58, current price ₹648.25 — Trading Above Calculated Value by 53.5%, margin of safety -100.0%.
What is the intrinsic value of SGRL?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Shree Ganesh Remedies (SGRL) is ₹301.58 (median value). With the current market price of ₹648.25, this represents a -53.5% variance from our estimated fair value.
The valuation range spans from ₹194.47 to ₹429.44, indicating ₹194.47 - ₹429.44.
Is SGRL undervalued or overvalued?
Based on our multi-method analysis, Shree Ganesh Remedies (SGRL) appears to be trading above calculated value by approximately 53.5%.
SGRL Financial Health — Key Ratios vs Industry Benchmarks
Shree Ganesh Remedies financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 3.74 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 14.7% | Industry Standard: 15%+ | Above 10% | Measures shareholder return efficiency |
| Operating Margin | 34.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.65x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
SGRL Cash Flow Quality — Operating & Free Cash Flow
Shree Ganesh Remedies operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹31 Cr | ₹13 Cr | Positive Free Cash Flow | 7/10 |
| March 2024 | ₹31 Cr | ₹15 Cr | Positive Free Cash Flow | 7/10 |
| March 2020 | ₹5 Cr | ₹4 Cr | Positive Free Cash Flow | 8/10 |
| March 2019 | ₹-5 Cr | ₹-5 Cr | Negative Cash Flow | 3/10 |